Presentation TCT 2022

Randomized, Double-Blind Trial of Routine Early Treatment With PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Presenter: Shamir Mehta

September 19, 2022

REGISTER for free or LOG IN to view this content

Randomized, Double-Blind Trial of Routine Early Treatment With PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

Coronary

TCT 2022

CAD Pharma

Up Next

Presentation TCT 2022

Prevention of Radial Artery Occlusion With Rivaroxaban After Transradial Coronary Procedures: The RIVARAD Multicentric Randomized Trial

Presenter: Rania Hammami

September 19, 2022

More slides +

Presentation TCT 2022

EXpansion of Stents After Intravascular lithoTripsy vs Conventional Predilatation in CALCified Coronary Arteries

Presenter: Maarten Vink

September 19, 2022

Presentation TCT 2022

Cutting Balloon to Optimize Predilatation for Stent Implantation: The COPS Randomized Trial

Presenter: Antonio Mangieri

September 19, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.